J D Douketis

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. pmc Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care
    J D Douketis
    CMAJ 160:513-25. 1999
  2. ncbi request reprint The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    Thromb Haemost 82:1028-32. 1999
  3. ncbi request reprint Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery
    J D Douketis
    Department of Medicine, St Joseph s Hospital, Hamilton, Ontario, Canada
    Chest 116:1240-6. 1999
  4. ncbi request reprint Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey
    J D Douketis
    St Joseph s Hospital, McMaster University, Hamilton, Canada
    Can J Cardiol 16:326-30. 2000
  5. ncbi request reprint The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Thromb Res 99:25-34. 2000
  6. ncbi request reprint Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
    J D Douketis
    St Joseph s Hospital, Room F 538, 50 Charlton Ave E, Hamilton, Ontario, Canada L8N 4A6
    Arch Intern Med 160:3431-6. 2000
  7. ncbi request reprint Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Med 110:515-9. 2001
  8. ncbi request reprint Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    J Thromb Haemost 3:943-8. 2005
  9. doi request reprint Irbesartan in patients with atrial fibrillation
    Salim Yusuf
    Population Health Research Institute, McMaster University, Hamilton, ON, Canada
    N Engl J Med 364:928-38. 2011
  10. ncbi request reprint Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice
    J D Douketis
    Department of Medicine, McMaster University, and St Joseph s Hospital, Hamilton, Ontario, Canada
    Am J Cardiovasc Drugs 1:245-51. 2001

Detail Information

Publications23

  1. pmc Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care
    J D Douketis
    CMAJ 160:513-25. 1999
    ....
  2. ncbi request reprint The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    Thromb Haemost 82:1028-32. 1999
    ..0 to 2.5, is effective in suppressing coagulation activation, and therefore, might be effective in preventing thromboembolism...
  3. ncbi request reprint Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery
    J D Douketis
    Department of Medicine, St Joseph s Hospital, Hamilton, Ontario, Canada
    Chest 116:1240-6. 1999
    ....
  4. ncbi request reprint Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey
    J D Douketis
    St Joseph s Hospital, McMaster University, Hamilton, Canada
    Can J Cardiol 16:326-30. 2000
    ..To survey physicians' anticoagulation preferences in patients with chronic atrial fibrillation who are undergoing elective surgery...
  5. ncbi request reprint The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Thromb Res 99:25-34. 2000
    ....
  6. ncbi request reprint Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
    J D Douketis
    St Joseph s Hospital, Room F 538, 50 Charlton Ave E, Hamilton, Ontario, Canada L8N 4A6
    Arch Intern Med 160:3431-6. 2000
    ....
  7. ncbi request reprint Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Med 110:515-9. 2001
    ..To determine if the location of deep vein thrombosis is a predictor of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy...
  8. ncbi request reprint Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    J Thromb Haemost 3:943-8. 2005
    ..Although hormone replacement therapy (HRT) is associated with an increased risk of deep vein thrombosis (DVT), it is not clear if the risk differs in users of combined estrogen-progestin HRT and estrogen-only HRT...
  9. doi request reprint Irbesartan in patients with atrial fibrillation
    Salim Yusuf
    Population Health Research Institute, McMaster University, Hamilton, ON, Canada
    N Engl J Med 364:928-38. 2011
    ..The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk...
  10. ncbi request reprint Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice
    J D Douketis
    Department of Medicine, McMaster University, and St Joseph s Hospital, Hamilton, Ontario, Canada
    Am J Cardiovasc Drugs 1:245-51. 2001
    ..Additionally, self-monitoring is limited to patients who have the cognitive and physical capabilities to perform the technique required for the portable coagulometer...
  11. ncbi request reprint A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency
    L R Dolovich
    Centre for Evaluation of Medicines, Department of Pharmacy, St Joseph s Hospital, Hamilton, Ontario, Canada
    Arch Intern Med 160:181-8. 2000
    ....
  12. ncbi request reprint Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis
    N S Lloyd
    Department of Medicine, McMaster University, and St Joseph s Healthcare, Hamilton, ON, Canada
    J Thromb Haemost 6:405-14. 2008
    ..We conducted a systematic review to determine whether anticoagulant prophylaxis reduces the risk of asymptomatic DVT compared to no prophylaxis in at-risk hospitalized medical patients...
  13. doi request reprint Dabigatran versus warfarin in patients with atrial fibrillation
    Stuart J Connolly
    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    N Engl J Med 361:1139-51. 2009
    ..Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor...
  14. doi request reprint Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
    Alexander G G Turpie
    McMaster University, Hamilton, Ontario L8L 2X2, Canada
    Lancet 373:1673-80. 2009
    ..We aimed to test the efficacy and safety of oral rivaroxaban for the prevention of venous thromboembolism after total knee arthroplasty...
  15. doi request reprint Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide
    E Jamula
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Thromb Haemost 6:1615-21. 2008
    ..The perioperative management of anticoagulation in patients who are having implantation of a pacemaker or implantable cardioverter defibrillator (ICD) is a common clinical problem in which best clinical practise is not established...
  16. ncbi request reprint The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    J Thromb Haemost 3:508-13. 2005
    ..1; 95% CI: 0.2-4.9). In patients who present with submassive PE, an elevated cTnI occurs in about one in seven patients and is associated with a 3.5-fold increased risk of all-cause death...
  17. doi request reprint The long-term risk of cancer in patients with a first episode of venous thromboembolism
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Thromb Haemost 7:546-51. 2009
    ..In patients with venous thromboembolism (VTE), 15-20% will have prevalent cancer when VTE is diagnosed but little is known about such patients' long-term risk, time course and predictors of new cancer...
  18. ncbi request reprint Treatment of warfarin-associated coagulopathy: a physician survey
    S E Wilson
    St. Joseph's Hospital, Hamilton, Ontario, Canada
    Chest 120:1972-6. 2001
    ..These findings highlight the need for randomized controlled trials to compare the efficacy of different routes of administration of vitamin K for warfarin-associated coagulopathy...
  19. ncbi request reprint Prognosis in pulmonary embolism
    J D Douketis
    Department of Medicine, St Joseph s Hospital, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada
    Curr Opin Pulm Med 7:354-9. 2001
    ....
  20. ncbi request reprint Acute renal vein thrombosis, oral contraceptive use, and hyperhomocysteinemia
    H H Chan
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Mayo Clin Proc 76:212-4. 2001
    ..In oral contraceptive users who develop venous thrombosis in the absence of other risk factors, clinicians should consider investigations for an underlying prothrombotic biochemical disorder...
  21. ncbi request reprint Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    Int J Obes (Lond) 29:1153-67. 2005
    ....
  22. ncbi request reprint Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism
    M Sohne
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 4:552-6. 2006
    ..Brain natriuretic peptide (BNP) is excreted from the cardiac ventricles in response to cardiomyocyte stretch and can be measured with an easy-to-perform blood test...
  23. ncbi request reprint Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials
    J W Eikelboom
    Thrombosis Unit, Department of Haematology, Royal Perth Hospital, Perth, Australia
    Lancet 358:9-15. 2001
    ..The reduction in risk is equivalent to about 20 symptomatic events per 1000 patients treated...